Pembrolizumab Monotherapy for NSCLC Extends Survival

    Cancer Discovery
    |June 7, 2018
    PubMed
    Summary

    Pembrolizumab, a PD-1 inhibitor, shows promise as a first-line treatment for advanced non-small cell lung cancer. Patients with PD-L1 expression (1% or higher) experienced improved survival and fewer side effects compared to chemotherapy.

    Related Concept Videos

    Survival Curves01:18

    Survival Curves

    Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
    The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
    723
    Survival Tree01:19

    Survival Tree

    Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
     Building a Survival Tree
    Constructing a...
    433
    Introduction To Survival Analysis01:18

    Introduction To Survival Analysis

    Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
    The primary goal of survival analysis is to estimate survival time—the time...
    811
    Comparing the Survival Analysis of Two or More Groups01:20

    Comparing the Survival Analysis of Two or More Groups

    Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
    609
    Truncation in Survival Analysis01:09

    Truncation in Survival Analysis

    Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
    Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
    625
    Assumptions of Survival Analysis01:15

    Assumptions of Survival Analysis

    Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
    433